We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.4%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.6B
AUM Growth
+$2.24B
(+5.5%)
Cap. Flow
-$670M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
15.36%
Holding
2,428
New
206
Increased
703
Reduced
1,198
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$204M |
| 2 |
JPMorgan Chase
JPM
|
+$72.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$67.5M |
| 4 |
Evergy
EVRG
|
+$66.6M |
| 5 |
NVIDIA
NVDA
|
+$58.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$370M |
| 2 |
United Parcel Service
UPS
|
+$364M |
| 3 |
Dominion Energy
D
|
+$172M |
| 4 |
Moderna
MRNA
|
+$125M |
| 5 |
Teladoc Health
TDOC
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.43% |
| 2 | Technology | 20.08% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 9.65% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
751
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.53M | 0.01% |
88,706
+88,621
| +104,260% | +$3.7M |
|
|
PRTY
752
DELISTED
Party City Holdco Inc.
PRTY
| $4.53M | 0.01% |
+1,741,378
| New | +$3.68M |
|
753
Aflac
AFL
$58.6B
| $4.53M | 0.01% |
124,508
+75,700
| +155% | +$2.76M |
|
754
Prelude Therapeutics
PRLD
$357M
| $4.52M | 0.01% |
+150,000
| New | +$4.24M |
|
755
Ironwood Pharmaceuticals
IRWD
$689M
| $4.51M | 0.01% |
501,341
-87,376
| -15% | -$868K |
|
756
O-I Glass
OI
$945M
| $4.51M | 0.01% |
425,582
+58,567
| +16% | +$626K |
|
757
Vanda Pharmaceuticals
VNDA
$302M
| $4.46M | 0.01% |
462,010
+203,873
| +79% | +$2.18M |
|
758
Helios Technologies
HLIO
$2.21B
| $4.46M | 0.01% |
122,526
| – | – |
|
|
SYNH
759
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.45M | 0.01% |
83,759
-9,394
| -10% | -$559K |
|
760
Puma Biotechnology
PBYI
$485M
| $4.43M | 0.01% |
438,877
-27,389
| -6% | -$279K |
|
761
Rocket Pharmaceuticals
RCKT
$382M
| $4.43M | 0.01% |
+193,626
| New | +$4.77M |
|
762
Graphic Packaging
GPK
$2.86B
| $4.4M | 0.01% |
312,416
+46,363
| +17% | +$658K |
|
763
TripAdvisor
TRIP
$1.05B
| $4.4M | 0.01% |
224,382
-27,274
| -11% | -$573K |
|
|
CCRD
764
DELISTED
CoreCard
CCRD
| $4.39M | 0.01% |
112,716
+14,668
| +15% | +$512K |
|
765
Teradata
TDC
$2.71B
| $4.37M | 0.01% |
192,432
+70,581
| +58% | +$1.57M |
|
|
DHR.PRA
766
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $4.35M | 0.01% |
2,950
| – | – |
|
767
Lumentum
LITE
$82.5B
| $4.33M | 0.01% |
57,634
-845
| -1% | -$70K |
|
|
TREB.U
768
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
| $4.32M | 0.01% |
+400,000
| New | +$4.23M |
|
769
Mid-America Apartment Communities
MAA
$14.1B
| $4.31M | 0.01% |
37,153
-1,803
| -5% | -$208K |
|
770
Nexstar Media Group
NXST
$5.04B
| $4.28M | 0.01% |
47,611
-3,105
| -6% | -$280K |
|
771
Amphenol
APH
$191B
| $4.27M | 0.01% |
315,472
+289,416
| +1,111% | +$3.81M |
|
772
Personalis
PSNL
$1.72B
| $4.27M | 0.01% |
197,013
+187,013
| +1,870% | +$3.72M |
|
773
Macerich
MAC
$6.36B
| $4.27M | 0.01% |
628,537
+423,060
| +206% | +$3.32M |
|
|
AGNT
774
AGNT Inc
AGNT
$652M
| $4.26M | 0.01% |
211,076
+210,506
| +36,931% | +$3.25M |
|
775
QCR Holdings
QCRH
$1.65B
| $4.23M | 0.01% |
154,158
-419
| -0.3% | -$12.4K |
|
Similar funds
Federated Hermes's Q3 2020 Portfolio in Review
As of Q3 2020, Federated Hermes held 2,428 positions worth $42.6B, up 5.5% from $40.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q3 2020 filing shows 206 new, 703 increased, 1,198 reduced and 187 closed positions. Its largest new stake was Snowflake: 234,132 shares worth $58.8M. The largest sale was Alibaba, an estimated $370M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q3 2020 buy was Snowflake: 234,132 shares worth $58.8M.
- Federated Hermes added most to Gilead Sciences in Q3 2020, an estimated $204M increase.
- Federated Hermes's biggest Q3 2020 reduction was Alibaba, cutting an estimated $370M.
- Federated Hermes fully exited BP in Q3 2020, selling an estimated $65.1M.
- Federated Hermes's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2020.
- Federated Hermes opened 206 new positions and closed 187 in Q3 2020.
- Federated Hermes's portfolio value rose 5.5% quarter-over-quarter to $42.6B.
Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.